Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 15, Issue -, Pages 10305-10320
Publisher
Informa UK Limited
Online
2020-12-17
DOI
10.2147/ijn.s282107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
- (2020) Pan Wu et al. Molecular Cancer
- Enzyme-Triggered Transcytosis of Dendrimer–Drug Conjugate for Deep Penetration into Pancreatic Tumors
- (2020) Guowei Wang et al. ACS Nano
- Aptamer/Peptide‐Functionalized Genome‐Editing System for Effective Immune Restoration through Reversal of PD‐L1‐Mediated Cancer Immunosuppression
- (2020) Xiao‐Yan He et al. ADVANCED MATERIALS
- Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives
- (2020) Weihong Tan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Taxane resistance in prostate cancer is mediated by decreased drug-target engagement
- (2020) Ada Gjyrezi et al. JOURNAL OF CLINICAL INVESTIGATION
- Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2020) Cora N. Sternberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) C. Parker et al. ANNALS OF ONCOLOGY
- Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
- (2020) Olivier Gires et al. CANCER AND METASTASIS REVIEWS
- Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
- (2020) James A. Eastham et al. JOURNAL OF CLINICAL ONCOLOGY
- The delivery challenge: fulfilling the promise of therapeutic genome editing
- (2020) Joost van Haasteren et al. NATURE BIOTECHNOLOGY
- The BCL-2 family saga
- (2020) Ana J. García-Sáez NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
- (2020) Marlon Perera et al. Nature Reviews Urology
- Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer
- (2020) Jakub Ptacek et al. NUCLEIC ACIDS RESEARCH
- Targeting p53 for the treatment of cancer
- (2020) Michael J. Duffy et al. SEMINARS IN CANCER BIOLOGY
- Gain-of-function mutant p53 in cancer progression and therapy
- (2020) Cen Zhang et al. Journal of Molecular Cell Biology
- Theranostic Nanoparticles for RNA-Based Cancer Treatment
- (2019) Richard A. Revia et al. ACCOUNTS OF CHEMICAL RESEARCH
- Cellular functions of long noncoding RNAs
- (2019) Run-Wen Yao et al. NATURE CELL BIOLOGY
- Tumor Targeting Strategies of Smart Fluorescent Nanoparticles and Their Applications in Cancer Diagnosis and Treatment
- (2019) Jiuyang He et al. ADVANCED MATERIALS
- Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway
- (2019) Tina Uroda et al. MOLECULAR CELL
- Selective Liposomal Transport through Blood Brain Barrier Disruption in Ischemic Stroke Reveals Two Distinct Therapeutic Opportunities
- (2019) Zahraa S. Al-Ahmady et al. ACS Nano
- Intra/Extracellular Lactic Acid Exhaustion for Synergistic Metabolic Therapy and Immunotherapy of Tumors
- (2019) Fan Gao et al. ADVANCED MATERIALS
- Intratumor Performance and Therapeutic Efficacy of PAMAM Dendrimers Carried by Clustered Nanoparticles
- (2019) Hong-Jun Li et al. NANO LETTERS
- Cellular RNA surveillance in health and disease
- (2019) Sandra L. Wolin et al. SCIENCE
- The approved gene therapy drugs worldwide: from 1998 to 2019
- (2019) Cui-Cui Ma et al. BIOTECHNOLOGY ADVANCES
- Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
- (2019) John F.R. Robertson et al. CLINICAL CANCER RESEARCH
- Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
- (2018) Mitchell G. Lawrence et al. EUROPEAN UROLOGY
- LncRNA Meg3 protects endothelial function by regulating the DNA damage response
- (2018) Mohamed Sham Shihabudeen Haider Ali et al. NUCLEIC ACIDS RESEARCH
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
- (2017) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment
- (2017) Chunai Gong et al. JOURNAL OF CONTROLLED RELEASE
- From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
- (2017) Avi Ashkenazi et al. NATURE REVIEWS DRUG DISCOVERY
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo
- (2016) D. Dibra et al. CLINICAL CANCER RESEARCH
- Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer
- (2016) Santosh Gupta et al. CLINICAL CANCER RESEARCH
- Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy
- (2016) Yujin Kim et al. Journal of Thoracic Oncology
- Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer
- (2015) Gang Luo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression
- (2015) Weizhao Peng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis
- (2015) Andre L. Moreira et al. Journal of Thoracic Oncology
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
- (2013) Jie Ni et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting long non-coding RNA to therapeutically upregulate gene expression
- (2013) Claes Wahlestedt NATURE REVIEWS DRUG DISCOVERY
- Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer
- (2013) Zuoren Yu et al. Nature Communications
- Role of the EpCAM (CD326) in prostate cancer metastasis and progression
- (2012) Jie Ni et al. CANCER AND METASTASIS REVIEWS
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
- (2009) Jing Shan et al. MOLECULAR CELL
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started